DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$0.78
+0.04 (+4.88%)
Open$0.79
Previous Close$0.75
Day High$0.81
Day Low$0.77
52W High$3.78
52W Low$0.69
Volume—
Avg Volume227.6K
Market Cap14.27M
P/E Ratio—
EPS$-0.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+425.3% upside
Current
$0.78
$0.78
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.68M | 3.58M | 6.37M |
| Net Income | -21,807,885 | -41,866,673 | 1.14M |
| Profit Margin | -1,300.7% | -1,235.6% | 17.9% |
| EBITDA | -19,397,119 | -39,307,301 | 1.58M |
| Free Cash Flow | — | — | 772.3K |
| Rev Growth | -53.1% | -53.1% | +7.5% |
| Debt/Equity | 2.42 | 2.42 | 0.72 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |